Anticancer potential of curcumin: Preclinical and clinical studies

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 363-398

  Aggarwal, Bharat B ^a   Kumar, Anushree ^a   Bharti, Alok C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anticancer agents; AP 1; Chemopreventive agents; COX 2; Curcumin; Cyclin D1; NF KB

Indexed keywords

CHEMOKINE; CORTICOSTEROID; CURCUMIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; LIPOXYGENASE; NITRIC OXIDE SYNTHASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; UROKINASE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER THERAPY; CATARACT; CELL PROLIFERATION; CLINICAL TRIAL; DOSE RESPONSE; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG TRANSFORMATION; EYE DISEASE; GENE ACTIVITY; GENE REPRESSION; GLAUCOMA; HUMAN; INTESTINE CANCER; MULTIGENE FAMILY; NONHUMAN; ONCOGENE NEU; OPTIC NERVE LESION; ORBIT PSEUDOTUMOR; PRIORITY JOURNAL; RETINA MACULA EDEMA; REVIEW; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; TOXICITY; TUMOR CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CLINICAL TRIALS; CURCUMA; CURCUMIN; HUMANS;

EID: 0037236792     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (337)

1. Rao DS, Sekhara NC, Satyanarayana MN and Srinivasan M: Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr 100: 1307-15, 1970.
2. Patil TN and Srinivasan M: Hypocholesteremic effect of curcumin in induced hypercholesteremic rats. Indian J Exp Biol 9: 167-9, 1971.
3. Keshavarz K: The influence of turmeric and curcumin on cholesterol concentration of eggs and tissues. Poult Sci 55: 1077-83, 1976.
4. Soudamini KK, Unnikrishnan MC, Soni KB and Kuttan R: Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol 36: 239-43, 1992.
5. Soni KB and Kuttan R: Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36: 273-5, 1992.
6. Hussain MS and Chandrasekhara N: Effect on curcumin on cholesterol gall-stone induction in mice. Indian J Med Res 96: 288-91, 1992.
7. Asai A and Miyazawa T: Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131: 2932-5, 2001.
8. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baro L, Ramirez-Tortosa CL, Martinez-Victoria E and Gil A: Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147: 371-8, 1999.
9. Naidu KA and Thippeswamy NB: Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol Cell Biochem 229: 19-23, 2002.
10. Patro BS, Rele S, Chintalwar GJ, Chattopadhyay S, Adhikari S and Mukherjee T: Protective activities of some phenolic 1,3-diketones against lipid peroxidation: possible involvement of the 1,3-diketone moiety. Chembiochem 3: 364-70, 2002.
11. Srivastava R, Puri V, Srimal RC and Dhawan BN: Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. Arzneimittelforschung 36: 715-7, 1986.
12. Srivastava KC, Bordia A and Verma SK: Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 52: 223-7, 1995.
13. Srivastava R, Dikshit M, Srimal RC and Dhawan BN: Antithrombotic effect of curcumin. Thromb Res 40: 413-7, 1985.
14. Dikshit M, Rastogi L, Shukla R and Srimal RC: Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res 101: 31-5, 1995.
15. Nirmala C and Puvanakrishnan R: Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochem Pharmacol 51: 47-51, 1996.
16. Nirmala C and Puvanakrishnan R: Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 159: 85-93, 1996.
17. Venkatesan N: curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 124: 425-7, 1998.
18. Srinivasan M: Effect of curcumin on blood sugar as seen in a diabetic subject. Indian J Med Sci 26: 269-70, 1972.
19. Babu PS and Srinivasan K: Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152: 13-21, 1995.
20. Babu PS and Srinivasan K: Hypolipidernic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166: 169-75, 1997.
21. Suresh Babu P and Srinivasan K: Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181: 87-96, 1998.
22. Arun N and Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57: 41-52, 2002.
23. Deodhar SD, Sethi R and Srimal RC: Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 71: 632-4, 1980.
24. Natarajan C and Bright JJ: Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168: 6506-13, 2002.
25. Lim GP, Chu T, Yang F, Beech W, Frautschy SA and Cole GM: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-7, 2001.
26. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME and Cole GM: Phenolic anti-inflammatory antioxidant reversal of a beta-induced cognitive deficits and neuropathology. Neurobiol Aging 22: 993-1005, 2001.
27. Sui Z, Salto R, Li J, Craik C and Ortiz de Montellano PR: Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1: 415-22, 1993.
28. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS and Pardee AB: Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90: 1839-42, 1993.
29. Jordan WC and Drew CR: Curcumin - a natural herb with anti-HIV activity. J Natl Med Assoc 88: 333, 1996.
30. Mazumder A, Nearnati N, Sunder S, Schulz J, Pertz H, Eich E and Pommier Y: curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem 40: 3057-63, 1997.
31. Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S and Bahraoui E: Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 149: 43-52, 1998.
32. Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC and Maheshwari RK: Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6: 167-77, 1998.
33. Phan TT, See P, Lee ST and Chan SY: Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J Trauma 51: 927-31, 2001.
34. Shahed AR, Jones E and Shoskes D: Quercetin and curcumin upregulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. Transplant Proc 33: 2988, 2001.
35. Morikawa T, Matsuda H, Ninomiya K and Yoshikawa M: Medicinal foodstuffs. XXIX. Potent protective effects of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver injury induced by D-galactosamine/lipopolysaccharide or tumor necrosis factor-alpha. Biol Pharm Bull 25: 627-31, 2002.
36. Ramprasad C and Sirsi M: Studies on Indian medicinal plants: Curcuma longa Linn.- effect of curcumin & the essential oils of C. longa on bile secretion. J Sci Industr Res 15: 262-265, 1956.
37. Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M and Awasthi YC: Curcumin protects against 4-hydroxy-2-transnonenal-induced cataract formation in rat lenses. Am J Clin Nutr 64: 761-6, 1996.
38. Venkatesan N and Chandrakasan G: Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142: 79-87, 1995.
39. Venkatesan N, Punithavathi V and Chandrakasan G: Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61: PL51-8, 1997.
40. Venkatesan N: Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci 66: PL21-8, 2000.
41. Punithavathi D, Venkatesan N and Babu M: Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 131: 169-72, 2000.
42. Saleheen D, Ali SA, Ashfaq K, Siddiqui AA, Agha A and Yasinzai MM: Latent activity of curcumin against leishmaniasis in vitro. Biol Pharm Bull 25: 386-9, 2002.
43. Gomes Dde C, Alegrio LV, de Lima ME, Leon LL and Araujo CA: Synthetic derivatives of curcumin and their activity against Leishmania amazonensis. Arzneimittelforschung 52: 120-4, 2002.
44. Koide T, Nose M, Ogihara Y, Yabu Y and Ohta N: Leishmanicidal effect of curcumin in vitro. Biol Pharm Bull 25: 131-3, 2002.
45. Huang HC, Jan TR and Yeh SF: Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 221: 381-4, 1992.
46. Chen HW and Huang HC: Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 124: 1029-40, 1998.
47. Srimal RC and Dhawan BN: Pharmacology of diferuloylmethane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25: 447-52, 1973.
48. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD and Huang MT: Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31: 385-96, 1991.
49. Majeed M, Badmaev V and Murray F: Turmeric and the healing curcuminoids: their amazing antioxidant properties and protective powers. New Canaan: Keats Publishing Inc: 1-46. 1996.
50. Surh YJ: Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 40: 1091-7, 2002.
51. Bremner P and Heinrich M: Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol 54: 453-72, 2002.
52. Gescher AJ, Sharma RA and Steward WP: Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol 2: 371-9, 2001.
53. Chignell CF, Bilski P, Reszka KJ, Motten AG, Sik RH and Dahl TA: Spectral and photochemical properties of curcumin. Photochem Photobiol 59: 295-302, 1994.
54. Das KC and Das CK: curcumin (diferuloylmethane), a singlet oxygen ((1)0(2)) quencher. Biochem Biophys Res Commun 295: 62-6, 2002.
55. Toniolo R, Di Narda F, Susmel S, Martelli M, Martelli L and Bontempelli G: Quenching of superoxide ions by curcumin. A mechanistic study in acetonitrile. Ann Chim 92: 281-8, 2002.
56. Dahl TA, Bilski P, Reszka KJ and Chignell CF: Photocytotoxicity of curcumin. Photochem Photobiol 59: 290-4, 1994.
57. Tonnesen HH and Karlsen J: Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 180: 402-4, 1985.
58. Tonnesen HH, Karlsen J and van Henegouwen GB: Studies on curcumin and curcuminoids. VIII. Photochemical stability of curcumin. Z Lebensm Unters Forsch 183: 116-22, 1986.
59. Tonnesen HH, de Vries H, Karlsen J and Beijersbergen van Henegouwen G: Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. J Pharm Sci 76: 371-3, 1987.
60. Tonnesen H, Masson M and Loftsson T: Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 244: 127, 2002.
61. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY and Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15: 1867-76, 1997.
62. Chen YC, Kuo TC, Lin-Shiau SY and Lin JK: Induction of HSP70 gene expression by modulation of Ca(+2) ion and cellular p53 protein by curcumin in colorectal carcinoma cells. Mol Carcinog 17: 224-34, 1996.
63. Jiang MC, Yang-Yen HF, Yen JJ and Lin JK: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26: 111-20, 1996.
64. Kuo ML, Huang TS and Lin JK: Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317: 95-100, 1996.
65. Mehta F, Pantazis P, McQueen T and Aggarwal BB: Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8: 470-81, 1997.
66. Verma SP, Salamone E and Goldin B: Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem Biophys Res Commun 233: 692-6, 1997.
67. Hanif R, Qiao L, Shiff SJ and Rigas B: Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med 130: 576-84, 1997.
68. Samaha HS, Kelloff GJ, Steele V, Rao CV and Reddy BS: Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57: 1301-5, 1997.
69. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S and Delage C: Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 129: 111-6, 1998.
70. Jee SH, Shen SC, Tseng CR, Chiu HC and Kuo ML: Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 111: 656-61, 1998.
71. Nogaki A, Satoh K, Iwasaka K, Takano H, Takahama M, Ida Y and Sakagami H: Radical intensity and cytotoxic activity of curcumin and gallic acid. Anticancer Res 18: 3487-91, 1998.
72. Piwocka K, Zablocki K, Wieckowski MR, Skierski J, Feiga I, Szopa J, Drela N, Wojtczak L and Sikora E: A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp Cell Res 249: 299-307, 1999.
73. Khar A, Ali AM, Pardhasaradhi BV, Begum Z and Anjum R: Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett 445: 165-8, 1999.
74. Han SS, Chung ST, Robertson DA, Ranjan D and Bondada S: Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93: 152-61, 1999.
75. Ramachandran C and You W: Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat 54: 269-78, 1999.
76. Chen H, Zhang ZS, Zhang YL and Zhou DY: Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19: 3675-80, 1999.
77. Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BV and Khar A: Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456: 311-4, 1999.
78. Elattar TM and Virji AS: The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 20: 1733-8, 2000.
79. Bielak-Zmijewska A, Koronkiewicz M, Skierski J, Piwocka, K, Radziszewska E and Sikora E: Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38: 131-8, 2000.
80. Cipriani B, Borsellino G, Knowles H, Tramonti D, Cavaliere F, Bernardi G, Battistini L and Brosnan CF: Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol 167: 3454-62, 2001.
81. Pan MH, Chang WL, Lin-Shiau SY, Ho CT, Lin JK: Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 49: 1464-74, 2001.
82. Morin D, Barthelemy S, Zini R, Labidalle S and Tillement JP: Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett 495: 131-6, 2001.
83. Moragoda L, Jaszewski R and Majumdar AP: Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res 21: 873-8, 2001.
84. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P and Aggarwal BB: Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20: 7597-609, 2001.
85. Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T and Sa G: Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun 288: 658-65, 2001.
86. Kim MS, Kang HJ and Moon A: Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch Pharm Res 24: 349-54, 2001.
87. Piwocka K, Jaruga E, Skierski J, Gradzka I and Sikora E: Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells. Free Radic Biol Med 31: 670-8, 2001.
88. Bush JA, Cheung KJ, Jr. and Li G: Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271: 305-14, 2001.
89. Mori H, Niwa K, Zheng Q, Yamada Y, Sakata K and Yoshimi N: Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat Res 480-481: 201-7, 2001.
90. Khar A, Ali AM, Pardhasaradhi BV, Varalakshmi CH, Anjum R and Kumari AL: Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 6: 368-76, 2001.
91. Choudhuri T, Pal S, Agwarwal ML, Das T and Sa G: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512: 334-40, 2002.
92. Anto RJ, Mukhopadhyay A, Denning K and Aggarwal BB: Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bel-2 and Bcl-xl. Carcinogenesis 23: 143-50, 2002.
93. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY and Orlowski RZ: Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 62: 3868-75, 2002.
94. Gautam SC, Xu YX, Pindolia KR, Janakiraman N and Chapman RA: Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). Biochem Pharmacol 55: 1333-7, 1998.
95. Ramsewak RS, DeWitt DL and Nair MG: Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7: 303-8, 2000.
96. Singh AK, Sidhu GS, Deepa T and Maheshwari RK: Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett 107: 109-15, 1996.
97. Sup Shim J, Hoon Kim D, Jung HJ, Hee Kim J, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J and Jeong Kwon H: Hydrazinocurcumin, a novel synthetic curcumin derivative, Is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 10: 2439-44, 2002.
98. Park MJ, Kim EH, Park IC, Lee HC, Woo SH, Lee JY, Hong YJ, Rhee CH, Choi SH, Shim BS, Lee SH and Hong SI: Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21 WAF1/CIP1, p27KIP1 and p53. Int J Oncol 21: 379-83, 2002.
99. Khafif A, Schantz SP, Chou TC, Edelstein D and Sacks PG: Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 19: 419-24, 1998.
100. Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J and Radziszewska E: Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54: 899-907, 1997.
101. Jaruga E, Bielak-Zmijewska A, Sikora E, Skierski J, Radziszewska E, Piwocka K and Bartosz G: Glutathione-independent mechanism of apoptosis inhibition by curcumin in rat thymocytes. Biochem Pharmacol 56: 961-5, 1998.
102. Jaruga E, Salvioli S, Dobrucki J, Chrul S, Bandorowicz-Pikula J, Sikora E, Franceschi C, Cossarizza A and Bartosz G: Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett 433: 287-93, 1998.
103. Jaruga E, Sokal A, Chrul S and Bartosz G: Apoptosis-independent alterations in membrane dynamics induced by curcumin. Exp Cell Res 245: 303-12, 1998.
104. Ozaki K, Kawata Y, Amano S and Hanazawa S: Stimulatory effect of curcumin on osteoclast apoptosis. Biochem Pharmacol 59: 1577-81, 2000.
105. Gomez-Lechon MJ, O'Connor E, Castell JV and Jover R: Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes. Toxicol Sci 65: 299-308, 2002.
106. Singh S and Aggarwal BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270: 24995-5000, 1995.
107. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA and Gautam SC: Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol 2-5: 413-22, 1997.
108. Surh YJ, Han SS, Keum YS, Seo HJ and Lee SS: Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-κB and AP-1. Biofactors 12: 107-12, 2000.
109. Han SS, Keum YS, Seo HJ and Surh YJ: Curcumin suppresses activation of NF-κB, and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35: 337-42, 2002.
110. Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M and Cheng AL: Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NFkappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol 63: 1709-16, 2002.
111. Chan MM: Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49: 1551-6, 1995.
112. Jang MK, Sohn DH and Ryu JH: A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67: 550-2, 2001.
113. Abe Y, Hashimoto S and Horie T: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39: 41-7, 1999.
114. Literat A, Su F, Norwicki M, Durand M, Ramanathan R, Jones CA, Minoo P and Kwong KY: Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 70: 253-67, 2001.
115. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA and Sartor RB: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163: 3474-83, 1999.
116. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda O, Mita S, Setoguchi T and Ogawa M: Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95: 1206-14, 2002.
117. Lin LI, Ke YF, Ko YC and Lin JK: Curcumin inhibits SK-Hep-I hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55: 349-53, 1998.
118. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB and Fini ME: Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 2 75: 10405-12, 2000.
119. Liacini A, Sylvester J, Li WQ and Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappaB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21: 251-62, 2002.
120. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S and Minami A: Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 277: 7865-74, 2002.
121. Kumar A, Dhawan S, Hardegen NJ and Aggarwal BB: curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-κB activation. Biochem Pharmacol 55: 775-83, 1998.
122. Gupta B and Ghosh B: Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21: 745-57, 1999.
123. Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Muller M, Mackman N, Ziegler R and Nawroth PP: The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB. Thromb Haemost 77: 772-82, 1997.
124. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K and Dannenberg AJ: Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20: 445-51, 1999.
125. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S and Howells L: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18: 6013-20, 1999.
126. Goel A, Boland CR and Chauhan DP: Specific inhibition of cyclooxygenase-2 (COX2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172: 111-8, 2001.
127. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK and Lee SS: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480-481: 243-68, 2001.
128. Chan MM, Huang HI, Fenton MR and Fong D: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55: 1955-62, 1998.
129. Brouet I and Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206: 533-40, 1995.
130. Chan MM, Ho CT and Huang HI: Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96: 23-9, 1995.
131. Pan MH, Lin-Shiau SY and Lin JK: Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through downregulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 60: 1665-76, 2000.
132. Onoda M and Inano H: Effect of curcumin on the production of nitric oxide by cultured rat mammary gland. Nitric Oxide 4: 505-15, 2000.
133. Hour TC, Chen J, Huang CY, Guan JY, Lu SH and Pu YS: Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21 (WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51: 211-8, 2002.
134. Huang TS, Lee SC and Lin JK: Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88: 52926, 1991.
135. Hanazawa S, Takeshita A, Amano S, Semba T, Nirazuka T, Katoh H and Kitano S: Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J Biol Chem 268: 9526-32, 1993.
136. Kakar SS and Roy D: Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett 87: 85-9, 1994.
137. Lu YP, Chang RL, Lou YR, Huang MT, Newmark HL, Reuhl KR and Conney AH: Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in J136 cells and in mouse epidermis. Carcinogenesis 15: 2363-70, 1994.
138. Xu YX, Pindolia KR, Janakiraman N, Chapman RA and Gautarn SC: Curcumin inhibits IL-1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11: 49-62, 1997.
139. Chen X, He Q, Liu W, Xu Q, Ye Y, Fu B and Yu L: AP-1 mediated signal transduction in thrombin-induced regulation of PAL-1 expression in human mesangial cells. Chin Med J (Engl) 113: 514-9, 2000.
140. Pendurthi UR and Rao LV: Suppression of transcription factor Egr-1 by curcumin. Thromb Res 97: 179-89, 2000.
141. Nakamura K, Yasunaga Y, Segawa T, Ko D, Moul JW, Srivastava S and Rhim JS: curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 21: 825-30, 2002.
142. Korutla L and Kumar R: Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1224: 597-600, 1994.
143. Korutla L, Cheung JY, Mendelsohn J and Kumar R: Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16: 1741-5, 1995.
144. Hong RL, Spohn WH and Hung MC: Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res 5: 1884-91, 1999.
145. Dorai T, Gehani N and Katz A: Therapeutic potential of curcumin in human prostate cancer. II. curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 4: 1-6, 2000.
146. Liu JY, Lin SJ and Lin JK: Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol13-acetate in NIH 3T3 cells. Carcinogenesis 14: 857-61, 1993.
147. Reddy S and Aggarwal BB: Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341: 19-22, 1994.
148. Hasmeda M and Polya GM: Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 42: 599-605, 1996.
149. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD and Conney AH: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51: 813-9, 1991.
150. Skrzypczak-Jankun E, McCabe NP, Selman SH and Jankun J: curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. Int J Mol Med 6: 521-6, 2000.
151. Susan M and Rao MN: Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittelforschung 42: 962-4, 1992.
152. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R and Vermeulen NP: Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol 51: 39-45, 1996.
153. Awasthi S, Pandya U, Singhal SS, Lin JT, Thiviyanathan V, Seifert WE, Jr., Awasthi YC and Ansari GA: Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1. Chem Biol Interact 128: 19-38, 2000.
154. Lin JK and Shih CA: Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3 T3 cells. Carcinogenesis 15: 1717-21, 1994.
155. Kaul S and Krishnakanth TP: Effect of retinol deficiency and curcumin or turmeric feeding on brain Na(+)-K+ adenosine triphosphatase activity. Mol Cell Biochem 137: 101-7, 1994.
156. Thaphyal R and Maru GB: Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol 39: 541-7, 2001.
157. Ciolino HP, Daschner PJ, Wang TT and Yeh GC: Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol 56: 197-206, 1998.
158. 2+. J Biol Chem 276: 46905-11, 2001.
159. Logan-Smith MJ, East JM and Lee AG: Evidence for a global inhibitor-induced conformation change on the Ca(2+)-ATPase of sarcoplasmic reticulum, from paired inhibitor studies. Biochemistry 41: 2869-75, 2002.
160. Bilmen JG, Khan SZ, Javed MH and Michelangeli F: Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 268: 6318-27, 2001.
161. Sumbilla C, Lewis D, Hammerschmidt T and Inesi G: The slippage of the Ca2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum. J Biol Chem 277: 13900-6, 2002.
162. Yamamoto H, Hanada K, Kawasaki K and Nishijima M: Inhibitory effect on curcumin on mammalian phospholipase D activity. FEBS Lett 417: 196-8, 1997.
163. Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY and Kim TS: Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128: 380-4, 1999.
164. Kang BY, Chung SW, Chung W, Im S, Hwang SY and Kim TS: Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384: 191-5, 1999.
165. Santibanez JF, Quintanilla M and Martinez J: Genistein and curcumin block TGF-beta 1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal keratinocytes. Nutr Cancer 37: 49-54, 2000.
166. Fenton JI, Wolff MS, Orth MW and Hord NG: Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. Carcinogenesis 23: 1065-70, 2002.
167. Motterlini R, Foresti R, Bassi R and Green CJ: Curcumin, an antioxidant and antiinflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28: 1303-12, 2000.
168. Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ and Motterlini R: Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61: 554-61, 2002.
169. Romiti N, Tongiani R, Cervelli F and Chieli E: Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 62: 2349-58, 1998.
170. Snyder RD and Arnone MR: Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 503: 21-35, 2002.
171. Kato K, Ito H, Kamei K and Iwamoto I: Stimulation of the stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. Cell Stress Chaperones 3: 152-60, 1998.
172. Chen X, Hasuma T, Yano Y, Yoshimata T, Morishima Y, Wang Y and Otani S: Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res 17: 2555-64, 1997.
173. Siebenlist U, Franzoso G and Brown K: Structure, regulation and function of NFkappa B. Annu Rev Cell Biol 10: 405-55, 1994.
174. Baeuerle PA and Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-79, 1994.
175. Grilli M, Chiu JJ and Lenardo MJ: NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 143: 1-62, 1993.
176. Baeuerle PA: The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta 1072: 63-80, 1991.
177. Brennan P and O'Neill LA: Inhibition of nuclear factor kappaB by direct modification in whole cells - mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 55: 965-73, 1998.
178. Ishii H, Takada K, Higuchi T and Sugiyama J: Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NFkappaB/Rel and AP-1. Thromb Haemost 84: 712-21, 2000.
179. Anto RJ, Maliekal TT and Karunagaran D: L-929 cells harboring ectopically expressed ReIA resist curcumin-induced apoptosis. J Biol Chem 275: 15601-4, 2000.
180. Bharti AC, Donato N, Singh S and Aggarwal BB: Curcumin (diferuloylmethane) downregulates the constitutive activation of nuclear factor-kappaB and I kappa B alpha kinase in human multiple myeloma cells leading to suppression of proliferation and induction of apoptosis. Blood (in press).
181. Aggarwal BB: Apoptosis and transcription factor NF-kB: a tale of association and dissociation. Biochem Pharmacol 60: 1033-1039, 2000.
182. Shishodia S and Aggrwal BB: Nuclear factor-kappa B activation: a question of life and death. J Biochem Mol Biol 35: 28-40, 2002.
183. Karunagaran D and Aggarwal BB: Transcription factors as targets for the drug development. In: Keri G, Toth I, eds. Molecular Pathomechanisms and New Trends in Drug Development. New York: Harwood Academic Publisher, 2002: 76-91.
184. Dhar A, Young MR, Colburn NH: The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the J136 model is predictive. Mol Cell Biochem 234235: 185-93, 2002.
185. Shaulian E and Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E 131-6, 2002.
186. Hsu TC, Young MR, Cmarik J and Colburn NH: Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 28: 1338-48, 2000.
187. Dong Z, Lavrovsky V and Colburn NH: Transformation reversion induced in J136 RT101 cells by AP-1 inhibitors. Carcinogenesis 16: 749-56, 1995.
188. Chen YR, Zhou G and Tan TH: c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide. Mol Pharmacol 56: 1271-9, 1999.
189. Hahm ER, Cheon G, Lee J, Kim B, Park C and Yang CH: New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett 184: 89-96, 2002.
190. Ammon HP, Safayhi H, Mack T and Sabieraj J: Mechanism of antiinflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 38: 113-9, 1993.
191. Sherr CJ: D-type cyclins. Trends Biochem Sci 20: 187-90, 1995.
192. Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7: 812-21, 1993.
193. Bartkova J, Lukas J, Strauss M and Bartek J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 58: 568-73, 1994.
194. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57: 353-61, 1994.
195. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-7, 1994.
196. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M et al.: Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54: 3107-10, 1994.
197. Dickson C, Fantl V, Gillett C, Brookes S, Bartek J, Smith R, Fisher C, Barnes D and Peters G: Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett 90: 43-50, 1995.
198. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J: Abnormal patterns of D-type cyclin expression and GI regulation in human head and neck cancer. Cancer Res 55: 949-56, 1995.
199. Adelaide J, Monges G, Derderian C, Seitz JF and Birnbaum D: Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71: 64-8, 1995.
200. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB and Holt PR: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110: 669-74, 1996.
201. Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldi F, Wolner E and Giordano A: Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol 20: 746-50, 1999.
202. Gumbiner LM, Gumerlock PH, Mack PC, Chi SG, deVere White RW, Mohler JL, Pretlow TG and Tricoli JV: Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate 38: 40-5, 1999.
203. Drobnjak M, Osman I, Scher HI, Fazzari M and Cordon-Cardo C: Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 6: 1891-5, 2000.
204. Harari D and Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 19: 6102-14, 2000.
205. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 66971, 1994.
206. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y and Beauchamp RD: Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 61: 5389-95, 2001.
207. Fantl V, Stamp G, Andrews A, Rosewell I and Dickson C: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9: 2364-72, 1995.
208. Sicinski P and Weinberg RA: A specific role for cyclin D1 in mammary gland development. J Mammary Gland Biol Neoplasia 2: 335-42, 1997.
209. Fantl V, Creer A, Dillon C, Bresnick J, Jackson D, Edwards P, Rosewell I and Dickson C: Fibroblast growth factor signalling and cyclin D1 function are necessary for normal mammary gland development during pregnancy. A transgenic mouse approach. Adv Exp Med Biol 480: 1-7, 2000.
210. Yu Q, Geng Y and Sicinski P: Specific protection against breast cancers by cyclin D1 ablation. Nature 411: 1017-21, 2001.
211. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG: Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270: 23589-97, 1995.
212. Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ and Pestell RG: Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem 274: 25245-9, 1999.
213. Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines GK, 3rd, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ and Pestell RG: Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol 20: 672-83, 2000.
214. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S and Herlyn M: Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res 59: 4876-81, 1999.
215. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, X., Liu M and Aggarwal BB: Curcumin-induced suppression of cell proliferation correlates with donregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene (in press).
216. Aggarwal BB and Natarajan K: Tumor necrosis factor: developments during the last dacade. Eur Cytokine Netw 7: 93-124, 1996.
217. Pober JS and Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70: 427-51, 1990.
218. Grau GE and Lou J: TNF in vascular pathology: the importance of plateletendothelium interactions. Res Immunol 144: 355-63, 1993.
219. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D and Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Faseb J 9: 899-909, 1995.
220. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK and Maheshwari RK: Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9: 305-12, 1998.
221. Shin EY, Kim SY and Kim EG: c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp Mol Med 33: 276-83, 2001.
222. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E and Byers HR: Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4: 376-83, 1998.
223. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV and Limtrakul PN: Modulation of P-glycoprotein expression and function by curcumin in multidrugresistant human KB cells. Biochem Pharmacol 64: 573-82, 2002.
224. Iersel ML, Ploemen JP, Struik I, van Amersfoort C, Keyzer AE, Schefferlie JG and van Bladeren PJ: Inhibition of glutathione S-transferase activity in human melanoma cells by alpha, betaunsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact 102: 117-32, 1996.
225. Rao TS, Basu N and Siddiqui HH: Anti-inflammatory activity of curcumin analogues. Indian J Med Res 75: 574-8, 1982.
226. Mukhopadhyay A Basu N, Ghatak N and Gujral PK: Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12: 508-15, 1982.
227. Srivastava R and Srimal RC: Modification of certain inflammation-induced biochemical changes by curcumin. Indian J Med Res 81: 215-23, 1985.
228. Reddy AC and Lokesh BR: Studies on anti-inflammatory activity of spice principles and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in rats. Ann Nutr Metab 38: 349-58, 1994.
229. Joe B and Lokesh BR: Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids 32: 1173-80, 1997.
230. Nagabhushan M, Amonkar AJ and Bhide SV: In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem Toxicol 25: 545-7, 1987.
231. Shalini VK and Srinivas L: Lipid peroxide induced DNA damage: protection by turmeric (Curcuma longa). Mol Cell Biochem 77: 3-10, 1987.
232. Shalini VK and Srinivas L: Fuel smoke condensate induced DNA damage in human lymphocytes and protection by turmeric (Curcuma longa). Mol Cell Biochem 95: 21-30, 1990.
233. Donatus IA, Sardjoko and Vermeulen NP: Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes. Biochem Pharmacol 39: 1869-75, 1990.
234. Srinivas L and Shalini VK: DNA damage by smoke: protection by turmeric and other inhibitors of ROS. Free Radic Biol Med 11: 277-83, 1991.
235. Azuine MA, Kayal JJ and Bhide SV: Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo [alpha] pyrene-induced genotoxicity and carcinogenicity. J Cancer Res Clin Oncol 118: 447-52, 1992.
236. Abraham SK, Sarma L and Kesavan PC: Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. Mutat Res 303: 109-12, 1993.
237. Soudamini KK, Unnikrishnan MC, Sukumaran K and Kuttan R: Mutagenicity and anti-mutagenicity of selected spices. Indian J Physiol Pharmacol 39: 347-53, 1995.
238. Oda Y: Inhibitory effect of curcumin on SOS functions induced by UV irradiation. Mutat Res 348: 67-73, 1995.
239. Deshpande SS and Maru GB: Effects of curcumin on the formation of benzo[a]pyrene derived DNA adducts in vitro. Cancer Lett 96: 71-80, 1995.
240. Anto RJ, George J, Babu KV, Rajasekharan KN and Kuttan R: Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res 370: 127-31, 1996.
241. Soni KB, Lahiri M, Chackradeo P, Bhide SV and Kuttan R: Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett 115: 129-33, 1997.
242. Ahsan H and Hadi SM: Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Lett 124: 23-30, 1998.
243. Antunes LM, Araujo MC, Dias FL and Takahashi CS: Modulatory effects of curcumin on the chromosomal damage induced by doxorubicin in Chinese hamster ovary cells. Teratog Carcinog Mutagen 19: 1-8, 1999.
244. Kelly MR, Xu J, Alexander KE and Loo G: Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutat Res 485: 309-18, 2001.
245. Araujo MC, Antunes LM and Takahashi CS: Protective effect of thiourea, a hydroxyl-radical scavenger, on curcumin-induced chromosomal aberrations in an in vitro mammalian cell system. Teratog Carcinog Mutagen 21: 175-80, 2001.
246. Holy JM: Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518: 71-84, 2002.
247. Shukla Y, Arora A and Taneja P: Antimutagenic potential of curcumin on chromosomal aberrations in Wistar rats. Mutat Res 515: 197-202, 2002.
248. Grandjean-Laquerriere A, Gangloff SC, Le Naour R, Trentesaux C, Hornebeck W and Guenounou M: Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18: 168-77, 2002.
249. Thresiamma KC, George J and Kuttan R: Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 34: 845-7, 1996.
250. Thresiamma KC, George J and Kuttan R: Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. J Exp Clin Cancer Res 17: 431-4, 1998.
251. Araujo MC, Dias FL and Takahashi CS: Potentiation by turmeric and curcumin of gamma-radiation-induced chromosome aberrations in Chinese hamster ovary cells. Teratog Carcinog Mutagen 19: 9-18, 1999.
252. Kapoor S and Priyadarsini KI: Protection of radiation-induced protein damage by curcumin. Biophys Chem 92: 119-26, 2001.
253. Varadkar P, Dubey P, Krishna M and Verma N: Modulation of radiation-induced protein kinase C activity by phenolics. J Radiol Prot 21: 361-70, 2001.
254. Oguro T and Yoshida T: Effect of ultraviolet A on ornithine decarboxylase and metallothionein gene expression in mouse skin. Photodermatol Photoimmunol Photomed 17: 71-8, 2001.
255. Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA and Melnick SJ: Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett 184: 1-6, 2002.
256. Holder GM, Plummer JL and Ryan AJ: The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8: 761-8, 1978.
257. Wahlstrom B and Blennow G: A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 43: 86-92, 1978.
258. Ravindranath V and Chandrasekhara N: Absorption and tissue distribution of curcumin in rats. Toxicology 16: 259-65, 1980.
259. Ravindranath V and Chandrasekhara N: In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 20: 251-7, 1981.
260. Ravindranath V and Chandrasekhara N: Metabolism of curcumin - studies with [3H]curcumin. Toxicology 22: 337-44, 1981.
261. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R and Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64: 353-6, 1998.
262. Pan MH, Huang TM and Lin JK: Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27: 486-94, 1999.
263. Mohandas KM and Desai DC: Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 18: 118-21, 1999.
264. Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P and Srimal RC: Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 13: 318-22, 1999.
265. Thaloor D, Miller KJ, Gephart J, Mitchell PO and Pavlath GK: Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol 277: C320-9, 1999.
266. Lin JK, Pan MH and Lin-Shiau SY: Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 13: 153-8, 2000.
267. Lal B, Kapoor AK, Agrawal PK, Asthana OP and Srimal RC: Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res 14: 443-7, 2000.
268. Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ and Sharma RA: Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 10: 1295-9, 2001.
269. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC and Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-900, 2001.
270. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ and Steward WP: Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7: 1894-900, 2001.
271. Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP and Gescher A: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61: 1058-64, 2001.
272. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Fanner PB, Steward WP and Gescher AJ: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11: 10511, 2002.
273. Hsu CH, Chuang SE, Hergenhahn M, Kuo ML, Lin JK, Hsieh CY and Cheng AL: Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan. Gan To Kagaku Ryoho 29 Suppl 1: 194-200, 2002.
274. Sharma RA, Ireson CR, Verschoyle RD, Hill KA, Williams ML, Leuratti C, Manson MM, Marnett LJ, Steward WP and Gescher A: Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res 7: 1452-8, 2001.
275. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP and Gescher AJ: Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11: 535-40, 2002.
276. Kuttan R, Bhanumathy P, Nirmala K and George MC: Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29: 197-202, 1985.
277. Kuttan R, Sudheeran PC and Josph CD: Turmeric and curcumin as topical agents in cancer therapy. Tumori 73: 29-31, 1987.
278. Huang MT, Smart RC, Wong CQ and Conney AH: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48: 5941-6, 1988.
279. Soudamini KK and Kuttan R: Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol 27: 227-33, 1989.
280. Soni KB, Rajan A and Kuttan R: Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett 66: 115-21, 1992.
281. Huang MT, Wang ZY, Georgiadis CA, Laskin JD and Conney AH: Inhibitory effects of curcumin on tumor initiation by benzo [a]pyrene and 7,12dimethylbenz[a]anthracene. Carcinogenesis 13: 2183-6, 1992.
282. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR and Conney AH: Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841-7, 1994.
283. Nagabhushan M and Bhide SV: Curcumin as an inhibitor of cancer. J Am Coll Nutr 11: 192-8, 1992.
284. Azuine MA and Bhide SV: Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17: 77-83, 1992.
285. Azuine MA and Bhide SV: Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis. Int J Cancer 51: 412-5, 1992.
286. Rao CV, Simi B and Reddy BS: Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14: 2219-25, 1993.
287. Lu YP, Chang RL, Huang MT and Conney AH: Inhibitory effect of curcumin on 120-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14: 293-7, 1993.
288. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Satoh K, Hara A and Ogawa H: Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res 54: 4653-9, 1994.
289. Azuine MA and Bhide SV: Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models. J Ethnopharmacol 44: 211-7, 1994.
290. Ghaisas SID and Bhide SV: In vitro studies on chemoprotective effect of Pumark against benzo(a)pyrene-induced chromosomal damage in human lymphocytes. Cell Biol Int 18: 21-7, 1994.
291. Rao CV, Rivenson A, Simi B and Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-66, 1995.
292. Rao CV, Rivenson A, Simi B and Reddy BS: Chemoprevention of colon cancer by dietary curcumin. Ann N Y Acad Sci 768: 201-4, 1995.
293. Huang MT, Ma W, Lu YP, Chang RL, Fisher C, Manchand PS, Newmark HL and Conney AH: Effects of curcumin, demethoxycurcumin, bisdemethexycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16: 2493-7, 1995.
294. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE and Lubet RA: Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12dimethylbenz[a] anthracene-induced mammary cancer in rats. Carcinogenesis 17: 1305-11, 1996.
295. Singletary K, MacDonald C, Wallig M and Fisher C: Inhibition of 7,12dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103: 137-41, 1996.
296. Ishizaki C, Oguro T, Yoshida T, Wen CQ, Sueki H and Iijima M: Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-otetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 193: 311-7, 1996.
297. Huang MT, Ma W, Yen P, Xie JG, Han J, Frenkel K, Grunberger D and Conney AH: Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 18: 83-8, 1997.
298. Limtrakul P, Lipigorngeson S, Namwong O, Apisariyakul A and Dunn FW: Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116: 197-203, 1997.
299. Takaba K, Hirose M, Yoshida Y, Kimura J, Ito N and Shirai T: Effects of ntritriacontane-16,18-dione, curcumin, chlorphyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model. Cancer Lett 113: 39-46, 1997.
300. Deshpande SS, Ingle AD and Maru GB: Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7,12-dimethylbenz [a]anthracene-induced rat mammary tumorigenesis. Cancer Lett 123: 35-40, 1998.
301. Singh SV, Hu X, Srivastava SK, Singh M, Xia H, Orchard JL and Zaren HA: Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis 19: 1357-60, 1998.
302. Krishnaswamy K, Goud VK, Sesikeran B, Mukundan MA and Krishna TP: Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin. Nutr Cancer 30: 163-6, 1998.
303. Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC and Awasthi S: Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 30: 445-56, 1998.
304. Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidzu N, Tanaka Y, Osawa T, Uraji T, Murakoshi M, Nishino H and Tsuda H: Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19: 81-5, 1998.
305. Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H and Ho CT: Effect of dietary curcumin and dibenzoylmethane on formation of 7,12dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 19: 1697-700, 1998.
306. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV and Reddy BS: Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59: 597-601, 1999.
307. Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H and Wakabayashi K: Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis 20: 1011-8, 1999.
308. Lee SK, Pezzuto JM: Evaluation of the potential of cancer chemopreventive activity mediated by inhibition of 12-O-tetradecanoyl phorbol 13-acetate-induced ornithine decarboxylase activity. Arch Pharm Res 22: 559-64, 1999.
309. Navis I, Sriganth P and Premalatha B: Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma. Pharmacol Res 39: 175-9, 1999.
310. Chun KS, Sohn Y, Kim HS, Kim OH, Park KK, Lee JM, Moon A, Lee SS and Surh YJ: Anti-tumor promoting potential of naturally occurring diarylheptanoids structurally related to curcumin. Mutat Res 428: 49-57, 1999.
311. Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV and Upadhyaya P: Evaluation of butylated hydroxyanisole, myoinositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung turnorigenesis in A/J mice. Cancer Lett 137: 123-30, 1999.
312. Churchill M, Chadbum A, Bilinski RT and Bertagnolli MM: Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89: 169-75, 2000.
313. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY and Cheng AL: Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21: 331-5, 2000.
314. Chuang SE, Cheng AL, Lin JK and Kuo ML: Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 38: 991-5, 2000.
315. Mariadason JM, Comer GA and Augenlicht LH: Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60: 4561-72, 2000.
316. Ushida J, Sugie S, Kawabata K, Pham QV, Tanaka T, Fujii K, Takeuchi H, Ito Y and Mori H: Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J Cancer Res 91: 893-8, 2000.
317. Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H and Wakabayashi K: Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis 21: 1835-41, 2000.
318. Lee SE, Campbell BC, Molyneux RJ, Hasegawa S and Lee HS: Inhibitory effects of naturally occurring compounds on aflatoxin B(1) biotransformation. J Agric Food Chem 49: 5171-7, 2001.
319. Thaphyal R, Deshpande SS and Maru GB: Effects of turmeric on the activities of benzo(a)pyrene-induced cytochrome P-450 isozymes. J Environ Pathol Toxicol Oncol 20: 59-63, 2001.
320. Ikezaki S, Nishikawa A, Furukawa F, Kudo K, Nakamura H, Tamura K and Mori H: Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride in rats. Anticancer Res 21: 3407-11, 2001.
321. Lin CC, Ho CT and Huang MT: Mechanistic studies on the inhibitory action of dietary dibenzoylmethane, a beta-diketone analogue of curcumin, on 7,12dimethylbenz[a]anthracene-induced mammary tumorigenesis. Proc Natl Sci Counc Repub China B 25: 158-65, 2001.
322. Limtrakul Pn P, Anuchapreeda S, Lipigomgoson S and Dunn FW: Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer 1: 1, 2001.
323. Sindhwani P, Hampton JA, Baig MM, Keck R and Selman SH: Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in OH mice. J Urol 166: 1498-501, 2001.
324. Lin CC, Lu YP, Lou YR, Ho CT, Newmark HH, MacDonald C, Singletary KW and Huang MT: Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice. Cancer Lett 168: 125-32, 2001.
325. Liao S, Lin J, Dang MT, Zhang H, Kao YH, Fukuchi J and Hiipakka RA: Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Arch Dermatol Res 293: 200-5, 2001.
326. Collett GP, Robson CN, Mathers JC and Campbell FC: curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis 22: 821-5, 2001.
327. Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL and Rosl F: The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Mol Carcinog 33: 137-45, 2002.
328. Inano H and Onoda M: Prevention of radiation-induced mammary tumors. Int J Radiat Oncol Biol Phys 52: 212-23, 2002.
329. Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Han C, Chen J, Huang MT and Yang CS: Inhibition of 7,12-dimethylbenz[a] anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23: 1307-13, 2002.
330. Huang MT, Deschner EE, Newmark HL, Wang ZY, Ferraro TA and Conney AH: Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett 64: 117-21, 1992.
331. Inano H and Onoda M: Radioprotective action of curcumin extracted from Curcuma longa Linn: inhibitory effect on formation of urinary 8-hydroxy-2′deoxyguanosine, tumorigenesis, but not mortality, induced by gamma-ray irradiation. Int J Radiat Oncol Biol Phys 53: 735-43, 2002.
332. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, Newmark HL and Bertagnolli MM: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21: 921-7, 2000.
333. Busquets S, Carbo N, Almendro V, Quiles MT, Lopez-Soriano FJ and Argiles JM: Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Lett 167: 33-8, 2001.
334. Dorai T, Cao YC, Dorai B, Buttyan R and Katz AE: Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47: 293-303, 2001.
335. Menon LG, Kuttan R and Kuttan G: Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 95: 221-5, 1995.
336. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington DC: World Cancer Research Fund American Institute for Cancer Research 1997.
337. Dyer JL, Khan SZ, Bilmen JG, Hawtin SR, Wheatley M, Javed MU and Michelangeli F: Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 31: 45-52, 2002.